In addition to the combination of PSMA PET with CT in diagnosis prostate lesions, the combination of multiparametric MRI (mpMRI) and PSMA PET has demonstrated substantial benefits in prostate cancer detection, localization, and staging. The gene discussed is FOLH1; the disease is prostate carcinoma.